2 ASX shares hitting 52-week lows – is this the bottom?

Coca Cola Amatil may be a complete bargain; McAleese Limited, not so much.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Coca Cola Amatil (ASX: CCL), Australia's resident Coke bottler, has been in the media crosshairs lately over its SPC Ardmona business. All the noise and the comparatively poor FY13 results generated as a result has seen Coca Cola's share price at its lowest ebb since early 2009. On the other hand, McAleese Limited (ASX: MCS) serves as yet another reminder why buying into an IPO is generally a bad idea.

Coca Cola Amatil

Our Coke bottler, fruit canner and would-be beer brewer extraordinaire is actually hitting its fourth 52-week low in three months, and at $10.96, it could prove to be a bargain.

Although its 2013 earnings were very poor, Coca Cola has largely sorted out its SPC Ardmona canning business, with Australia's two supermarket giants stepping in to provide stronger domestic demand. The supermarket supply arrangements should bolster Coca Cola's bottom line, and reinforce the confidence needed for its foray into the brewing business and southeast Asia.

There are a number of risks associated with the transition overseas, most notably cultural ones associated with the entry of Coca Cola into primarily Muslim nations like Indonesia. Given the (highly negative) media coverage followers of that religion often receive in Australia, it's easy for an investor to perceive overseas Muslim nations as strongly anti-Western and surmise that companies like Coca Cola face significant barriers to entry.

Regardless of the truth of that assumption, I think Coca Cola stands a solid chance of success overseas. For starters, it's a universal product – tastes great, provides a rush and is mildly addictive, and secondly, no one does brand research like Coke. Even if the formulation of Coke we buy here clashes with a southeast Asian palate or culture, Coca Cola Amatil is smart enough to do taste testing and culturally-targeted advertising.

The key to selling beverages is making people want to drink the product, and creating that desire is one of Coca Cola's greatest strengths. Coca Cola Amatil bottles more than just Coke, with their range including iced teas, nutrient waters and so on, further broadening their appeal. Time will tell, but I and a number of other Foolish contributors think Coca Cola Amatil provides a solid buyers opportunity at its current price.

McAleese Limited

The story is very different for McAleese, whose prospects for recovery are very different to Coca Cola's. While it may be technically unfair to cover McAleese in a list of 52-week lows (as an IPO, any price below its issue price is a 52-week low), I feel the falls are severe enough to warrant its inclusion. McAleese is down 68% from its listing at $1.47, to its current price of ~$0.485 as a result of losing several big contracts and restructuring its subsidiary, Coote's Transport.

McAleese's current price does not reflect a buying opportunity. At least not so soon after its IPO, not before you see an annual report, and not before more contracts show up to take the place of the outgoing petroleum contracts. It is possible that investors who buy at these depressed prices will see the face value of their shareholding rise. However, I also think that a purchase now would be more fairly described as gambling. Without concrete earnings and profitability info, investors are purchasing based on the face value of the company, not on the underlying cogs that make money. In the absence of any serious positive news, I think that McAleese could well have further to fall.

An honourable mention to Oroton Group

Investors looking for another great potential growth story at low prices should check out last week's 52-week lows for more info on Oroton Group (ASX: ORL), which is up only 3 cents since that time.

Foolish takeaway

The most important thing to take away from these 52-week low articles is that the share price is not a good measure of whether a company is a great investment. Investors need to look past the smoke and mirrors to see if there are any positives hidden from the public eye. With Coca Coca Amatil the answer is yes; southeast Asian expansions and beer brewing in Australia, plus improvement in SPC Ardmona. With McAleese at this stage, the situation is quite different.

Motley Fool contributor Sean O’Neill doesn’t own shares in any company listed.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »